The National Cancer Institute (NCI) is offering this Small Business Transition Grant to empower early-career academic scientists to transition into entrepreneurship, fostering the transfer of innovative technologies from university laboratories to small businesses. This grant addresses critical challenges faced during technology commercialization: identifying skilled teams and securing early-stage development funding. Primarily, this NCI grant is for providing both comprehensive entrepreneurial mentoring and essential product development support. It aims to accelerate the advancement of cutting-edge ideas into products that will benefit the U.S. population, bridging the gap between academic discovery and market-ready solutions through a strategic blend of expertise and financial backing.
Opportunity ID: 353724
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-023 |
| Funding Opportunity Title: | Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.172 — Human Genome Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 23, 2024 |
| Last Updated Date: | Apr 23, 2024 |
| Original Closing Date for Applications: | Aug 21, 2024 |
| Current Closing Date for Applications: | Aug 21, 2024 |
| Archive Date: | Sep 26, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR and STTR programs. As technologies transition from academic discovery to small businesses, two common challenges arise, identifying the right team with the right expertise to take the product into a small business, and funding for early-stage technology development. This NOFO seeks to address both challenges simultaneously by having two equally important goals: entrepreneurial mentoring support, and product development support. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-023.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 353724 Full Announcement-RFA-CA-24-023 -> RFA-CA-24-023-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00286018 | Jul 21, 2024 | Aug 21, 2024 | View |
Package 1
Mandatory forms
353724 RR_SF424_5_0-5.0.pdf
353724 PHS398_CoverPageSupplement_5_0-5.0.pdf
353724 RR_OtherProjectInfo_1_4-1.4.pdf
353724 PerformanceSite_4_0-4.0.pdf
353724 RR_KeyPersonExpanded_4_0-4.0.pdf
353724 RR_Budget_3_0-3.0.pdf
353724 RR_SubawardBudget30_3_0-3.0.pdf
353724 PHS398_ResearchPlan_5_0-5.0.pdf
353724 SBIR_STTR_Information_3_0-3.0.pdf
353724 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353724 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
